Upregulation of Monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-stage Renal Disease
Overview
Affiliations
Background And Objectives: Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification.
Design, Setting, Participants, & Measurements: We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects.
Results: Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function.
Conclusions: Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.
Tang Z, Yu S, Pan Y J Transl Med. 2023; 21(1):689.
PMID: 37789439 PMC: 10546717. DOI: 10.1186/s12967-023-04455-2.
Kaiser L, Quint I, Csuk R, Jung M, Deigner H Cells. 2021; 10(10).
PMID: 34685682 PMC: 8534767. DOI: 10.3390/cells10102703.
The Role of GPNMB in Inflammation.
Saade M, de Souza G, Scavone C, Kinoshita P Front Immunol. 2021; 12:674739.
PMID: 34054862 PMC: 8149902. DOI: 10.3389/fimmu.2021.674739.
Tsou P, Sawalha A FASEB J. 2020; 34(7):8810-8823.
PMID: 32445534 PMC: 7501235. DOI: 10.1096/fj.202000651.
Michalinos A, Tsaroucha A, Lambropoulou M, Schizas D, Valsami G, Kostomitsopoulos N Transl Gastroenterol Hepatol. 2020; 5:7.
PMID: 32190775 PMC: 7061179. DOI: 10.21037/tgh.2019.11.01.